您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2015, Vol. 53 ›› Issue (3): 17-21.doi: 10.6040/j.issn.1671-7554.0.2014.779

• 基础医学 • 上一篇    下一篇

CaSki细胞内HPVL1蛋白的表达

杜义江, 肖长义, 叶红, 汤桂成, 黎家华   

  1. 三峡大学医学院组织学与胚胎学教研室, 湖北 宜昌 443002
  • 收稿日期:2014-11-03 修回日期:2015-01-23 出版日期:2015-03-10 发布日期:2015-03-10
  • 通讯作者: 肖长义, E-mail:xiaochy@ctgu.edu.cn E-mail:xiaochy@ctgu.edu.cn
  • 基金资助:
    湖北省自然科学基金(2011CDC002)

Expression of human papillomavirus late capsid protein 1 in CaSki cells

DU Yijiang, XIAO Changyi, YE Hong, TANG Guicheng, LI Jiahua   

  1. Department of Histology and Embryology, Medicine College of China Three Gorges University, Yichang 443002, Hubei, China
  • Received:2014-11-03 Revised:2015-01-23 Online:2015-03-10 Published:2015-03-10

PDF (PC)

988

摘要： 目的 了解含人乳头瘤病毒(HPV)基因组的宫颈癌CaSki细胞中HPV晚期衣壳蛋白1(L1)的表达。方法 以多价HPV L1小鼠单克隆抗体做探针, 采用ELISA、免疫组化、Western blotting等方法, 检测CaSki细胞内L1蛋白的表达;采用RT-PCR法检测细胞内L1 mRNA的表达。结果 CaSki细胞呈HPV L1阳性反应, 显示细胞内有HPV L1蛋白存在;CaSki细胞内有L1 mRNA存在。结论 包含HPV16混合基因组的CaSki细胞可以表达L1蛋白。

关键词: CaSki细胞, 人乳头瘤病毒, 晚期衣壳蛋白1, 宫颈癌

Abstract: Objective To investigate the expression of human papil1omavirus (HPV) late capsid protein 1 (L1) in CaSki cells. Methods Using polyvalent HPV L1 mice monoclonal antibody as the probe, the L1 protein expression in CaSki cells was investigated by ELISA, immunohistochemistry and Western blotting. L1 mRNA expression was detected by RT-PCR. Results HPV L1 was strong positive in CaSki cells, indicating that L1 protein was expressed in CaSki cells. L1 mRNA was expressed in CaSki cells. Conclusion CaSki cells integrated HPV 16 DNA genome can express L1 protein.

Key words: Caski cells, Human papillomavirus, Uterine cervix cancer, Late capsid protein 1

中图分类号: 

  • R737.33
[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
[2] 李慧弘,肖长义,袁太宁,等.宫颈癌HeLa细胞内HPV L1蛋白表达的观察[J].中国免疫学杂志, 2013, 29(3):260-264. LI Huihong, XIAO Changyi, YUAN Taining, et al. The expression of human papillomaviurs late capsid protein 1 in Hela cells[J]. Chinese Journal of Immunology, 2013, 29(3):260-264.
[3] Baker CC, Phelps WC, Lindfren V, et al. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines[J]. J Virol, 1987, 61(4):962-971.
[4] Perez LO, Barbisan G, Ottino A, et al. Human papillomavirus DNA and oncogene alterations in colorectal tumors[J]. Pathol Oncol Res, 2010, 16(3):461-468.
[5] de Roda HA, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR[J]. J Gen Virol, 1995, 76 ( Pt 4):1057-1062.
[6] Jacobs MV, de Roda HA, van den Brule AJ, et al. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes[J]. J Clin Microbiol, 1995, 33(4):901-905.
[7] Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses[J]. J Clin Microbiol, 2000, 38(1):357-361.
[8] Zhang T, Xu Y, Xu X, et al. Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce interference among component types[J]. Vaccine, 2010, 28(19):3479-3487.
[9] Orozco JJ, Carter JJ, Koutsky LA, et al. Humoral immune response recognizes a complex set of epitopes on human papillomaviru stype 6 L1 capsomers[J]. Virol, 2005, 79(15):9503-9514.
[10] Nelson LM, Rose RC, Moroianu J. Nuclear import strategies of high risk HPV16 L1 major capsid protein[J]. Biol Chem, 2002, 277(26):23958-23964.
[11] Day PM, Kines RC, Thompson CD, et al. In vivo mechanisms of vaccine-induced protection against HPV infection[J]. Cell Host Microbe, 2010, 8(3):260-270.
[12] Wang XM, Cook JC, Lee JC, et al. Human papiL1omavirus type 6 virus-like particles present overlapping yet distinct conformational epitopes[J]. Gen Virol, 2003, 84(6):1493-1497.
[13] Wentzensen N, Ridder R, Klaes R, et al. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions[J]. Oncogene, 2002, 21(3):419-426.
[14] Choi YS, Kang WD, Kim SM, et al. Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1[J]. Int J Gynecol Cancer, 2010, 20(2):288-293.
[15] Lee H, Lee KJ, Jung CK, et al. Expression of HPV L1 capsid protein in cervical specimens with HPV infection[J]. Diagn Cytopathol, 2008, 36(12):864-867.
[16] Choi YS, Kang WD, Kim SM, et al. Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1[J]. Int J Gynecol Cancer, 2010, 20(2):288-293.
[17] Steele JC, Roberts S, Rookes SM, et al. Detection of CD4(+)- and CD8(+)-T-cell responses to human papillomavirus type 1 antigens expressed at various stages of the virus life cycle by using an enzyme-linked immunospot assay of gamma interferon release[J]. J Virol, 2002, 76(12):6027-6036.
[18] Griesser H, Sander H, Hilfrich R, et al. Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia[J]. Anal Quant Cytol Histol, 2004, 26(5):241-245.
[19] Chambers G, Millan D, Cuschieri K, et al. Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease[J]. J Med Virol, 2014, 86(4):627-633.
[20] Bin H, Ruifang W, Ruizhen L, et al. Detention of HPV L1 capsid protein and hTERC gene in screening of cervical cancer[J]. Iran J Basic Med Sci, 2013, 16(6):797-802.
[1] 王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54.
[2] 石军,牛子捷,王军,马丽晶,奚春花,肖洋. 幼年型复发性呼吸道乳头状瘤病肺部播散的临床特点及麻醉要点[J]. 山东大学学报 (医学版), 2024, 62(12): 82-89.
[3] 任慧欣,郑茂金,韩文灿,王超群,周云,裴冬生. 过氧化氢通过调控自噬增强宫颈癌的放疗敏感性[J]. 山东大学学报 (医学版), 2023, 61(6): 22-28.
[4] 刘萌,侯丛哲,麻焕玉,张震,赵新蕊,张萍,朱琳. β-雌二醇对宫颈癌Hela细胞增殖的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 9-15.
[5] 修德健,高正文,宋婷婷,崔楠,崔静,孙健平. 生物信息学方法分析与宫颈癌有关联的基因[J]. 山东大学学报 (医学版), 2022, 60(10): 99-109.
[6] 陈泉材,韩赛,刘露,孙雨,尤学武,张俊华,张友忠. CDC7、MCM4在105例宫颈病变组织中的表达及意义[J]. 山东大学学报 (医学版), 2022, 60(1): 34-39.
[7] 蔡春芳,易丹妮,郭芝亮,何耀娟. P16蛋白与TCT、HR-HPV的相关性及对不同子宫颈病变诊断的效能[J]. 山东大学学报 (医学版), 2022, 60(1): 40-47.
[8] 王璐,赵新蕊,朱琳. 25例早期宫颈癌无瘤化免举宫腹腔镜子宫切除术临床效果[J]. 山东大学学报 (医学版), 2021, 59(6): 76-80.
[9] 梁婷婷,杨勇霞,侯丛哲,黄太胜,王华丽,朱琳. PAX1基因甲基化与宫颈高级别上皮内病变及高危型HPV分型的关联性[J]. 山东大学学报 (医学版), 2021, 59(11): 48-52.
[10] 杨佳欣,沈铿,王遥. 妇科恶性肿瘤保留生育功能治疗的现状与展望[J]. 山东大学学报 (医学版), 2018, 56(5): 1-7.
[11] 陈颖,周小青,齐眉,张魏芳,刘娟,赵蔚明. 干扰PRPS2基因表达对宫颈癌细胞生物学特性的影响[J]. 山东大学学报 (医学版), 2018, 56(2): 9-13.
[12] 张文浩,乔立君,郑静怡,陈健行,张魏芳. 人乳头瘤病毒早期癌蛋白E6/E7稳定表达细胞系的构建及其对Rab12表达的影响[J]. 山东大学学报 (医学版), 2018, 56(12): 1-6.
[13] 王永,姜晨,周士英,杨晓玫. IQ结构域GTP酶激活蛋白3表达对宫颈癌细胞增殖和转移的影响[J]. 山东大学学报 (医学版), 2018, 56(10): 103-109.
[14] 丁长宽,陈健行. 蛋白酶体抑制剂硼替佐米联合顺铂对宫颈癌细胞增殖的影响[J]. 山东大学学报 (医学版), 2018, 56(1): 70-75.
[15] 刘京康,杨建勇,孟丽华,姜洁. 血清miR-17-92簇在HPV阳性宫颈癌中的早期诊断价值[J]. 山东大学学报（医学版）, 2017, 55(5): 86-90.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发